StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.98+0.01 (+0.51%)

Close on Nov 17, 2026Market cap $160.90MP/E –Yield –

Eledon Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Eledon Pharmaceuticals's market cap was $215.98M on Nov 11, 2026, against $97.61M a year earlier. Over the last 5 years it ranged from $18.87M to $298.86M, with a median of $68.24M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$215.98M+138.9%
2025Dec 31, 2025$90.42M-46.7%
2024Dec 31, 2024$169.67M+300.4%
2023Dec 29, 2023$42.38M+35.1%
2022Dec 30, 2022$31.37M-50.3%
2021Dec 31, 2021$63.09M+221.4%
2020Dec 31, 2020$19.63M+160.9%
2019Dec 31, 2019$7.52M-50.1%
2018Dec 31, 2018$15.07M-46.5%
2017Dec 29, 2017$28.19M+4016.0%
2016Dec 30, 2016$684.80K-88.8%
2015Dec 31, 2015$6.09M-38.8%
2014Dec 31, 2014$9.96M–

More Eledon Pharmaceuticals figures

See a number that looks wrong?